Hyderabad: Gene Solutions, an innovator in genetic testing across Asia, has joined hands with AMPATH (American Institute of Pathology and Laboratory Sciences) to inaugurate a state-of-the-art Genomics Laboratory in Hyderabad.
The collaboration is set to bring next-generation sequencing (NGS) technologies closer to patients and healthcare professionals, strengthening India’s access to precision medicine.
Genomics Laboratory to Advance Precision Diagnostics
The newly established Genomics Laboratory combines AMPATH’s wide-reaching diagnostic infrastructure – comprising 20 satellite laboratories and over 2,000 collection points – with Gene Solutions’ proven expertise in genomics.
Also Read: Avestagenome Project Partners with IISc to Advance Longevity and Genomics Research in India
This integration will deliver timely and reliable testing in areas including reproductive health, oncology, and personalized medicine.
The Hyderabad-based genomics laboratory will offer cutting-edge solutions such as:
- triSure NIPT – A non-invasive prenatal screening solution for chromosomal conditions, microdeletions, and select single-gene disorders, providing early and safe insights into fetal and maternal health.
- SPOT-MAS – A clinically validated early cancer detection test capable of identifying 75 types and subtypes of cancer from a single blood sample.
- K-TRACK and K-4CARE – Advanced cancer monitoring and genomic profiling solutions powered by multi-omics technology to support personalized treatment and recurrence monitoring.
Also Read: AFMC Pune Advances Military Medicine with AI, Genomics, Simulation Labs
Expanding Access to Genomics in India
The collaboration between Gene Solutions and AMPATH is focused on providing healthcare professionals with advanced diagnostic tools that enable:
- Safer prenatal screening with accurate early insights for expectant parents.
- Earlier cancer detection through simple blood-based genomic testing.
- Personalized oncology care by empowering oncologists with genomic insights for treatment planning and recurrence monitoring.
Highlighting the strategic alliance, Dr Nguyen Hoai Nghia, Co-founder and CEO of Gene Solutions, stated: “This partnership reflects a shared vision of making science-driven genetic testing more widely available. Working with AMPATH allows us to deliver advanced solutions through a trusted and familiar healthcare network.”
Echoing this, Dr Maneesh Bagai, COO of AMPATH, said: “We are excited to expand into next-generation sequencing through this collaboration. Together, we are redefining diagnostics in maternal health, cancer detection, and personalized oncology with a patient-centric approach.”
